XML 46 R34.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share-Based Payment (Tables)
 12 Months Ended
Dec. 31, 2023
Share-Based Payment [Abstract]  
Schedule of Number of Share Options and Their Related Weighted Average Exercise Prices Movements in the number of share options and their related weighted average exercise prices (in dollars) during the years ended December 31, 2023, 2022 and 2021 are as follows:
   Year ended December 31, 
   2023   2022   2021 
   Number of
options		   Weighted
average
exercise
price (USD)		   Number of
options		   Weighted
average
exercise
price		   Number of
options		   Weighted
average
exercise
price		 
                         
Outstanding at beginning of year   12,400,000    0.05    12,400,000    0.05    16,200,000    0.07 
Granted   150,000    0.01    -    -    -    - 
Exercised   -    -    -    -    -    - 
Expired   -    -    -    -    (3,433,331)   0.16 
Forfeited   -    -    -    -    (366,669)   0.08 
                               
Outstanding at end of year   12,550,000    0.05    12,400,000    0.05    12,400,000    0.05 
                               
Exercisable at end of year   12,550,000    0.05    10,733,330    0.05    7,399,998    0.07 

 
Schedule of Exercise Price and Remaining Contractual Life for Options Outstanding Below is information about the exercise price (in dollars) and the remaining contractual life (in years) for options outstanding at end of year:
December 31, 
2023   2022 
Options
outstanding at
end of year		   Range of
exercise prices
(USD)		   Weighted
average
remaining
contractual life		   Options
outstanding at
end of year		   Range of
exercise prices
(USD)		   Weighted
average
remaining
contractual life		 
                      
 10,900,000    0.03 - 0.14    6.07    10,900,000    0.03 - 0.14    6.94 
 1,500,000    0.17    1.66    1,500,000    0.17    2.66 
 150,000    0.01    9.17    -    -    - 
                            
 12,550,000              12,400,000           
December 31, 2021 
Options
outstanding at
end of year		   Range of
exercise prices
(USD)		   Weighted
average
remaining
contractual life		 
          
 10,900,000    0.03 - 0.14    7.94 
 1,500,000    0.17    3.66 
             
 12,400,000           
Schedule of Outstanding Options The table below summarizes the outstanding options as of December 31, 2023 that have been granted to the Company’s executives, directors and consultants
Options
 outstanding		   Position 

Grant

date (*)

  Exercise
price in
NIS		  

Fair value

USD in
thousands

   Vesting schedule
                   
 750,000   Four Directors  December 30, 2014   0.4325-0.4915    46   33.33% of the stock options vest following the lapse of 12 months from the grant date, and the remaining 66.67% vest in 8 equal portions each quarter over a period of 2 years from the first
 150,000   One Director  March 25, 2015   0.40    24   33.33% of the stock options vest following the lapse of 12 months from the grant date, and the remaining 66.67% vest in 8 equal portions each quarter over a period of 2 years from the first
 1,500,000   Chairman of Board  March 31, 2016   0.6    63   12 equal portions each quarter over a period of 3 years from the date of grant
 10,000,000   Chief Executive Officer  July 7, 2020   0.09    103   12 equal portions each quarter over a period of 3 years from the grant date
 150,000   Director  March 2, 2023   0.0495    1   Fully vested on date of grant
                      
 12,550,000                    
(*)Date of the Company's Board of Directors’ decision (or shareholders, if required). As of December 31, 2023, all options are vested and therefore there is no unrecognized compensation cost.

Schedule of Fair Value for Options Granted The fair value for options granted in 2023 is estimated at the date of grant using a Black-Scholes model with the following weighted average assumptions:
   March 2, 2023 
     
Dividend yield   0%
Expected volatility   67.5%
Risk-free interest   4.08%
Expected life (years)   10